Labat Africa Ltd
Labat Africa Limited, an investment holding company, engages in the technology, logistics, and healthcare activities in South Africa. The company operates through Technology, Logistics, and Healthcare segments. It engages in the manufacture and distribution of integrated circuits, including micro electronic systems; transportation of coals and minerals for mines; and sale of medical cannabis, as … Read more
Market Cap & Net Worth: Labat Africa Ltd (LAB)
Labat Africa Ltd (JSE:LAB) has a market capitalization of $4.42 Million (ZAC8.33 Billion) as of March 19, 2026. Listed on the JSE stock exchange, this South Africa-based company holds position #42519 globally and #185 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Labat Africa Ltd's stock price ZAC5.00 by its total outstanding shares 1665108879 (1.67 Billion).
Labat Africa Ltd Market Cap History: 2015 to 2026
Labat Africa Ltd's market capitalization history from 2015 to 2026. Data shows change from $132.74 Million to $4.42 Million (-27.15% CAGR).
Labat Africa Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Labat Africa Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.04x
Labat Africa Ltd's market cap is 0.04 times its annual revenue
1.00x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.06x
Labat Africa Ltd's market cap is 0.06 times its annual earnings
9.89x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $24.78 Million | $14.31 Million | $8.40 Million | 1.73x | 2.95x |
| 2017 | $33.63 Million | $52.01 Million | $4.64 Million | 0.65x | 7.24x |
| 2018 | $34.51 Million | $73.35 Million | $12.58 Million | 0.47x | 2.74x |
| 2019 | $36.28 Million | $616.43 Million | -$72.94 Million | 0.06x | N/A |
| 2020 | $38.05 Million | $40.25 Million | $946.00K | 0.95x | 40.22x |
| 2021 | $25.66 Million | $29.27 Million | -$22.75 Million | 0.88x | N/A |
| 2022 | $8.85 Million | $30.72 Million | -$48.11 Million | 0.29x | N/A |
| 2023 | $6.19 Million | $49.53 Million | -$86.90 Million | 0.13x | N/A |
| 2024 | $6.19 Million | $48.54 Million | -$25.80 Million | 0.13x | N/A |
| 2025 | $7.08 Million | $199.40 Million | $117.87 Million | 0.04x | 0.06x |
Competitor Companies of LAB by Market Capitalization
Companies near Labat Africa Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to Labat Africa Ltd by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #422 globally with a market cap of $51.61 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #432 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #452 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #422 | Zoetis Inc | NYSE:ZTS | $51.61 Billion | $117.35 |
| #432 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.31 |
| #452 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Labat Africa Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Labat Africa Ltd's market cap moved from $132.74 Million to $ 4.42 Million, with a yearly change of -27.15%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ZAC4.42 Million | -37.50% |
| 2025 | ZAC7.08 Million | +14.29% |
| 2024 | ZAC6.19 Million | 0.00% |
| 2023 | ZAC6.19 Million | -30.00% |
| 2022 | ZAC8.85 Million | -65.52% |
| 2021 | ZAC25.66 Million | -32.56% |
| 2020 | ZAC38.05 Million | +4.88% |
| 2019 | ZAC36.28 Million | +5.13% |
| 2018 | ZAC34.51 Million | +2.63% |
| 2017 | ZAC33.63 Million | +35.71% |
| 2016 | ZAC24.78 Million | -81.33% |
| 2015 | ZAC132.74 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Labat Africa Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.42 Million USD |
| MoneyControl | $4.42 Million USD |
| MarketWatch | $4.42 Million USD |
| marketcap.company | $4.42 Million USD |
| Reuters | $4.42 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.